Pharmaceuticals 2010, 3(6), 1779-1791; doi:10.3390/ph3061779

The Pharmacogenomics of Anti-Hypertensive Therapy

* email, email and email
Received: 2 March 2010; in revised form: 20 May 2010 / Accepted: 26 May 2010 / Published: 1 June 2010
(This article belongs to the Special Issue Personalized Medicine)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Hypertension is a major public health problem, but measures to reduce blood pressure and thus cardiovascular risk are complicated by the high prevalence of treatment resistance, despite the availability of multiple drugs. Drug side-effects contribute considerably to suboptimal blood pressure control. Clinicians must often rely on empirical methods to match patients with effective drug treatment. Hypertension pharmacogenomics seeks to find genetic predictors of response to drugs that lower blood pressure and to translate this knowledge into clinical practice. In this review we summarise the current status of hypertension pharmacogenetics from monogenic hypertension to essential hypertension and discuss the issues that need to be considered in a hypertension pharmacogenomic study.
Keywords: hypertension; pharmacogenetics; pharmacogenomics; beta-blockers; ACE inhibitors; angiotensin receptor blockers; antihypertensive; calcium channel blockers; thiazide diuretics
PDF Full-text Download PDF Full-Text [265 KB, uploaded 1 June 2010 17:09 CEST]

Export to BibTeX |

MDPI and ACS Style

Padmanabhan, S.; Paul, L.; Dominczak, A.F. The Pharmacogenomics of Anti-Hypertensive Therapy. Pharmaceuticals 2010, 3, 1779-1791.

AMA Style

Padmanabhan S, Paul L, Dominczak AF. The Pharmacogenomics of Anti-Hypertensive Therapy. Pharmaceuticals. 2010; 3(6):1779-1791.

Chicago/Turabian Style

Padmanabhan, Sandosh; Paul, Laura; Dominczak, Anna F. 2010. "The Pharmacogenomics of Anti-Hypertensive Therapy." Pharmaceuticals 3, no. 6: 1779-1791.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert